Study frailty during major surgery for gut cancer
Part of Cancer, Digestive system clinical trials.
This trial studies how “frailty” affects people with gastrointestinal (gut) cancer who are about to have major surgery, sometimes after chemotherapy or other treatment beforehand. It may help doctors better prepare and support patients through surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- You have a confirmed diagnosis of cancer in the gastrointestinal (gut) area
- You are scheduled for an elective major surgery for gut or related cancers (upper or lower gut, or liver/pancreas/bile ducts)
- Your care plan includes neoadjuvant treatment (treatment before surgery) followed by major surgery, or major surgery as part of your referral
- If you are pregnant, you cannot join
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how frailty affects recovery and outcomes for patients aged 70 and older who are having planned surgery to remove colorectal cancer. The goal is to better understand frailty's impact so care can be improved.
This study tests a frailty assessment and intervention program for people aged 65+ with stage II or III stomach cancer who will have surgery and chemotherapy afterward. It aims to improve recovery and quality of life.
This trial studies simple “frailty” assessments (tests of strength, memory, and daily functioning) to better predict risk in people with gynecologic cancers who are planning or having surgery. If you qualify, the results may help doctors identify who needs extra support before and after surgery.
This trial looks at whether “frailty” (how weak or vulnerable someone is) changes short- and long-term outcomes after surgery. It may help doctors better predict who could benefit from extra support before and after surgery.
This study looks at how certain blood markers (albumin/creatine ratio, vitamin B12, and folate) relate to frailty in older adults having surgery for stomach or intestinal cancer. The goal is to understand if these markers can help predict which patients may be more frail.
This study looks at “frailty,” or how well the body may handle stress, around the time of surgery in people age 65 and older. It may help doctors better understand who is at higher risk and how to plan care around surgery.
Hear when a new Gastrointestinal Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.